[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Preclinical DMPK Studies Market Growth (Status and Outlook) 2024-2030

July 2024 | 153 pages | ID: GE25F07B7B57EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

Drug metabolism and pharmacokinetics (DMPK) studies are a type of preclinical study that is used to assess the absorption, distribution, metabolism, and excretion (ADME) of a drug candidate. This information is essential for understanding how a drug will behave in the body and for designing safe and effective clinical trials.

DMPK studies can be performed in vitro or in vivo. In vitro DMPK studies are typically used to screen a large number of compounds for their ADME properties and to identify promising candidates for further development. In vivo DMPK studies are typically performed later in drug development, after a compound has been shown to have promising ADME properties in vitro.

The global Preclinical DMPK Studies market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LPI (LP Information)' newest research report, the “Preclinical DMPK Studies Industry Forecast” looks at past sales and reviews total world Preclinical DMPK Studies sales in 2022, providing a comprehensive analysis by region and market sector of projected Preclinical DMPK Studies sales for 2023 through 2029. With Preclinical DMPK Studies sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Preclinical DMPK Studies industry.

This Insight Report provides a comprehensive analysis of the global Preclinical DMPK Studies landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Preclinical DMPK Studies portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Preclinical DMPK Studies market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Preclinical DMPK Studies and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Preclinical DMPK Studies.

United States market for Preclinical DMPK Studies is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Preclinical DMPK Studies is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Preclinical DMPK Studies is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Preclinical DMPK Studies players cover Charles River, Labcorp, Eurofins Scientific, PPD, Inotiv, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Preclinical DMPK Studies market by product type, application, key players and key regions and countries.

Segmentation by Type:
  • In Vitro
  • In Vivo
Segmentation by Application:
  • Pharmaceutical Companies
  • Medical Device Companies
  • Others
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
Segmentation by Type:
  • In Vitro
  • In Vivo
Segmentation by Application:
  • Pharmaceutical Companies
  • Medical Device Companies
  • Others
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Charles River
  • Labcorp
  • Eurofins Scientific
  • PPD
  • Inotiv
  • ChemPartner
  • Evotec
  • Medicilon
  • Crown Bioscience
  • Jubilant Biosys
  • Creative Biolabs
  • Allucent
  • Sai Life Sciences
  • Sygnature Discovery
  • Q2 Solutions
  • Invitrocue
  • Frontage
  • BioDuro-Sundia
  • Wuxi AppTec
  • Pharmaron
  • JOINN Laboratories
  • Tigermed
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Preclinical DMPK Studies Market Size 2019-2030
  2.1.2 Preclinical DMPK Studies Market Size CAGR by Region (2019 VS 2023 VS 2030)
  2.1.3 World Current & Future Analysis for Preclinical DMPK Studies by Country/Region, 2019, 2023 & 2030
2.2 Preclinical DMPK Studies Segment by Type
  2.2.1 In Vitro
  2.2.2 In Vivo
2.3 Preclinical DMPK Studies Market Size by Type
  2.3.1 Preclinical DMPK Studies Market Size CAGR by Type (2019 VS 2023 VS 2030)
  2.3.2 Global Preclinical DMPK Studies Market Size Market Share by Type (2019-2024)
2.4 Preclinical DMPK Studies Segment by Application
  2.4.1 Pharmaceutical Companies
  2.4.2 Medical Device Companies
  2.4.3 Others
2.5 Preclinical DMPK Studies Market Size by Application
  2.5.1 Preclinical DMPK Studies Market Size CAGR by Application (2019 VS 2023 VS 2030)
  2.5.2 Global Preclinical DMPK Studies Market Size Market Share by Application (2019-2024)

3 PRECLINICAL DMPK STUDIES MARKET SIZE BY PLAYER

3.1 Preclinical DMPK Studies Market Size Market Share by Player
  3.1.1 Global Preclinical DMPK Studies Revenue by Player (2019-2024)
  3.1.2 Global Preclinical DMPK Studies Revenue Market Share by Player (2019-2024)
3.2 Global Preclinical DMPK Studies Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 PRECLINICAL DMPK STUDIES BY REGION

4.1 Preclinical DMPK Studies Market Size by Region (2019-2024)
4.2 Global Preclinical DMPK Studies Annual Revenue by Country/Region (2019-2024)
4.3 Americas Preclinical DMPK Studies Market Size Growth (2019-2024)
4.4 APAC Preclinical DMPK Studies Market Size Growth (2019-2024)
4.5 Europe Preclinical DMPK Studies Market Size Growth (2019-2024)
4.6 Middle East & Africa Preclinical DMPK Studies Market Size Growth (2019-2024)

5 AMERICAS

5.1 Americas Preclinical DMPK Studies Market Size by Country (2019-2024)
5.2 Americas Preclinical DMPK Studies Market Size by Type (2019-2024)
5.3 Americas Preclinical DMPK Studies Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Preclinical DMPK Studies Market Size by Region (2019-2024)
6.2 APAC Preclinical DMPK Studies Market Size by Type (2019-2024)
6.3 APAC Preclinical DMPK Studies Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Preclinical DMPK Studies Market Size by Country (2019-2024)
7.2 Europe Preclinical DMPK Studies Market Size by Type (2019-2024)
7.3 Europe Preclinical DMPK Studies Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Preclinical DMPK Studies by Region (2019-2024)
8.2 Middle East & Africa Preclinical DMPK Studies Market Size by Type (2019-2024)
8.3 Middle East & Africa Preclinical DMPK Studies Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL PRECLINICAL DMPK STUDIES MARKET FORECAST

10.1 Global Preclinical DMPK Studies Forecast by Region (2025-2030)
  10.1.1 Global Preclinical DMPK Studies Forecast by Region (2025-2030)
  10.1.2 Americas Preclinical DMPK Studies Forecast
  10.1.3 APAC Preclinical DMPK Studies Forecast
  10.1.4 Europe Preclinical DMPK Studies Forecast
  10.1.5 Middle East & Africa Preclinical DMPK Studies Forecast
10.2 Americas Preclinical DMPK Studies Forecast by Country (2025-2030)
  10.2.1 United States Market Preclinical DMPK Studies Forecast
  10.2.2 Canada Market Preclinical DMPK Studies Forecast
  10.2.3 Mexico Market Preclinical DMPK Studies Forecast
  10.2.4 Brazil Market Preclinical DMPK Studies Forecast
10.3 APAC Preclinical DMPK Studies Forecast by Region (2025-2030)
  10.3.1 China Preclinical DMPK Studies Market Forecast
  10.3.2 Japan Market Preclinical DMPK Studies Forecast
  10.3.3 Korea Market Preclinical DMPK Studies Forecast
  10.3.4 Southeast Asia Market Preclinical DMPK Studies Forecast
  10.3.5 India Market Preclinical DMPK Studies Forecast
  10.3.6 Australia Market Preclinical DMPK Studies Forecast
10.4 Europe Preclinical DMPK Studies Forecast by Country (2025-2030)
  10.4.1 Germany Market Preclinical DMPK Studies Forecast
  10.4.2 France Market Preclinical DMPK Studies Forecast
  10.4.3 UK Market Preclinical DMPK Studies Forecast
  10.4.4 Italy Market Preclinical DMPK Studies Forecast
  10.4.5 Russia Market Preclinical DMPK Studies Forecast
10.5 Middle East & Africa Preclinical DMPK Studies Forecast by Region (2025-2030)
  10.5.1 Egypt Market Preclinical DMPK Studies Forecast
  10.5.2 South Africa Market Preclinical DMPK Studies Forecast
  10.5.3 Israel Market Preclinical DMPK Studies Forecast
  10.5.4 Turkey Market Preclinical DMPK Studies Forecast
10.6 Global Preclinical DMPK Studies Forecast by Type (2025-2030)
10.7 Global Preclinical DMPK Studies Forecast by Application (2025-2030)
  10.7.1 GCC Countries Market Preclinical DMPK Studies Forecast

11 KEY PLAYERS ANALYSIS

11.1 Charles River
  11.1.1 Charles River Company Information
  11.1.2 Charles River Preclinical DMPK Studies Product Offered
  11.1.3 Charles River Preclinical DMPK Studies Revenue, Gross Margin and Market Share (2019-2024)
  11.1.4 Charles River Main Business Overview
  11.1.5 Charles River Latest Developments
11.2 Labcorp
  11.2.1 Labcorp Company Information
  11.2.2 Labcorp Preclinical DMPK Studies Product Offered
  11.2.3 Labcorp Preclinical DMPK Studies Revenue, Gross Margin and Market Share (2019-2024)
  11.2.4 Labcorp Main Business Overview
  11.2.5 Labcorp Latest Developments
11.3 Eurofins Scientific
  11.3.1 Eurofins Scientific Company Information
  11.3.2 Eurofins Scientific Preclinical DMPK Studies Product Offered
  11.3.3 Eurofins Scientific Preclinical DMPK Studies Revenue, Gross Margin and Market Share (2019-2024)
  11.3.4 Eurofins Scientific Main Business Overview
  11.3.5 Eurofins Scientific Latest Developments
11.4 PPD
  11.4.1 PPD Company Information
  11.4.2 PPD Preclinical DMPK Studies Product Offered
  11.4.3 PPD Preclinical DMPK Studies Revenue, Gross Margin and Market Share (2019-2024)
  11.4.4 PPD Main Business Overview
  11.4.5 PPD Latest Developments
11.5 Inotiv
  11.5.1 Inotiv Company Information
  11.5.2 Inotiv Preclinical DMPK Studies Product Offered
  11.5.3 Inotiv Preclinical DMPK Studies Revenue, Gross Margin and Market Share (2019-2024)
  11.5.4 Inotiv Main Business Overview
  11.5.5 Inotiv Latest Developments
11.6 ChemPartner
  11.6.1 ChemPartner Company Information
  11.6.2 ChemPartner Preclinical DMPK Studies Product Offered
  11.6.3 ChemPartner Preclinical DMPK Studies Revenue, Gross Margin and Market Share (2019-2024)
  11.6.4 ChemPartner Main Business Overview
  11.6.5 ChemPartner Latest Developments
11.7 Evotec
  11.7.1 Evotec Company Information
  11.7.2 Evotec Preclinical DMPK Studies Product Offered
  11.7.3 Evotec Preclinical DMPK Studies Revenue, Gross Margin and Market Share (2019-2024)
  11.7.4 Evotec Main Business Overview
  11.7.5 Evotec Latest Developments
11.8 Medicilon
  11.8.1 Medicilon Company Information
  11.8.2 Medicilon Preclinical DMPK Studies Product Offered
  11.8.3 Medicilon Preclinical DMPK Studies Revenue, Gross Margin and Market Share (2019-2024)
  11.8.4 Medicilon Main Business Overview
  11.8.5 Medicilon Latest Developments
11.9 Crown Bioscience
  11.9.1 Crown Bioscience Company Information
  11.9.2 Crown Bioscience Preclinical DMPK Studies Product Offered
  11.9.3 Crown Bioscience Preclinical DMPK Studies Revenue, Gross Margin and Market Share (2019-2024)
  11.9.4 Crown Bioscience Main Business Overview
  11.9.5 Crown Bioscience Latest Developments
11.10 Jubilant Biosys
  11.10.1 Jubilant Biosys Company Information
  11.10.2 Jubilant Biosys Preclinical DMPK Studies Product Offered
  11.10.3 Jubilant Biosys Preclinical DMPK Studies Revenue, Gross Margin and Market Share (2019-2024)
  11.10.4 Jubilant Biosys Main Business Overview
  11.10.5 Jubilant Biosys Latest Developments
11.11 Creative Biolabs
  11.11.1 Creative Biolabs Company Information
  11.11.2 Creative Biolabs Preclinical DMPK Studies Product Offered
  11.11.3 Creative Biolabs Preclinical DMPK Studies Revenue, Gross Margin and Market Share (2019-2024)
  11.11.4 Creative Biolabs Main Business Overview
  11.11.5 Creative Biolabs Latest Developments
11.12 Allucent
  11.12.1 Allucent Company Information
  11.12.2 Allucent Preclinical DMPK Studies Product Offered
  11.12.3 Allucent Preclinical DMPK Studies Revenue, Gross Margin and Market Share (2019-2024)
  11.12.4 Allucent Main Business Overview
  11.12.5 Allucent Latest Developments
11.13 Sai Life Sciences
  11.13.1 Sai Life Sciences Company Information
  11.13.2 Sai Life Sciences Preclinical DMPK Studies Product Offered
  11.13.3 Sai Life Sciences Preclinical DMPK Studies Revenue, Gross Margin and Market Share (2019-2024)
  11.13.4 Sai Life Sciences Main Business Overview
  11.13.5 Sai Life Sciences Latest Developments
11.14 Sygnature Discovery
  11.14.1 Sygnature Discovery Company Information
  11.14.2 Sygnature Discovery Preclinical DMPK Studies Product Offered
  11.14.3 Sygnature Discovery Preclinical DMPK Studies Revenue, Gross Margin and Market Share (2019-2024)
  11.14.4 Sygnature Discovery Main Business Overview
  11.14.5 Sygnature Discovery Latest Developments
11.15 Q2 Solutions
  11.15.1 Q2 Solutions Company Information
  11.15.2 Q2 Solutions Preclinical DMPK Studies Product Offered
  11.15.3 Q2 Solutions Preclinical DMPK Studies Revenue, Gross Margin and Market Share (2019-2024)
  11.15.4 Q2 Solutions Main Business Overview
  11.15.5 Q2 Solutions Latest Developments
11.16 Invitrocue
  11.16.1 Invitrocue Company Information
  11.16.2 Invitrocue Preclinical DMPK Studies Product Offered
  11.16.3 Invitrocue Preclinical DMPK Studies Revenue, Gross Margin and Market Share (2019-2024)
  11.16.4 Invitrocue Main Business Overview
  11.16.5 Invitrocue Latest Developments
11.17 Frontage
  11.17.1 Frontage Company Information
  11.17.2 Frontage Preclinical DMPK Studies Product Offered
  11.17.3 Frontage Preclinical DMPK Studies Revenue, Gross Margin and Market Share (2019-2024)
  11.17.4 Frontage Main Business Overview
  11.17.5 Frontage Latest Developments
11.18 BioDuro-Sundia
  11.18.1 BioDuro-Sundia Company Information
  11.18.2 BioDuro-Sundia Preclinical DMPK Studies Product Offered
  11.18.3 BioDuro-Sundia Preclinical DMPK Studies Revenue, Gross Margin and Market Share (2019-2024)
  11.18.4 BioDuro-Sundia Main Business Overview
  11.18.5 BioDuro-Sundia Latest Developments
11.19 Wuxi AppTec
  11.19.1 Wuxi AppTec Company Information
  11.19.2 Wuxi AppTec Preclinical DMPK Studies Product Offered
  11.19.3 Wuxi AppTec Preclinical DMPK Studies Revenue, Gross Margin and Market Share (2019-2024)
  11.19.4 Wuxi AppTec Main Business Overview
  11.19.5 Wuxi AppTec Latest Developments
11.20 Pharmaron
  11.20.1 Pharmaron Company Information
  11.20.2 Pharmaron Preclinical DMPK Studies Product Offered
  11.20.3 Pharmaron Preclinical DMPK Studies Revenue, Gross Margin and Market Share (2019-2024)
  11.20.4 Pharmaron Main Business Overview
  11.20.5 Pharmaron Latest Developments
11.21 JOINN Laboratories
  11.21.1 JOINN Laboratories Company Information
  11.21.2 JOINN Laboratories Preclinical DMPK Studies Product Offered
  11.21.3 JOINN Laboratories Preclinical DMPK Studies Revenue, Gross Margin and Market Share (2019-2024)
  11.21.4 JOINN Laboratories Main Business Overview
  11.21.5 JOINN Laboratories Latest Developments
11.22 Tigermed
  11.22.1 Tigermed Company Information
  11.22.2 Tigermed Preclinical DMPK Studies Product Offered
  11.22.3 Tigermed Preclinical DMPK Studies Revenue, Gross Margin and Market Share (2019-2024)
  11.22.4 Tigermed Main Business Overview
  11.22.5 Tigermed Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION


LIST OF TABLES

Table 1. Preclinical DMPK Studies Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions)
Table 2. Preclinical DMPK Studies Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of In Vitro
Table 4. Major Players of In Vivo
Table 5. Preclinical DMPK Studies Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ millions)
Table 6. Global Preclinical DMPK Studies Market Size by Type (2019-2024) & ($ millions)
Table 7. Global Preclinical DMPK Studies Market Size Market Share by Type (2019-2024)
Table 8. Preclinical DMPK Studies Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions)
Table 9. Global Preclinical DMPK Studies Market Size by Application (2019-2024) & ($ millions)
Table 10. Global Preclinical DMPK Studies Market Size Market Share by Application (2019-2024)
Table 11. Global Preclinical DMPK Studies Revenue by Player (2019-2024) & ($ millions)
Table 12. Global Preclinical DMPK Studies Revenue Market Share by Player (2019-2024)
Table 13. Preclinical DMPK Studies Key Players Head office and Products Offered
Table 14. Preclinical DMPK Studies Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Preclinical DMPK Studies Market Size by Region (2019-2024) & ($ millions)
Table 18. Global Preclinical DMPK Studies Market Size Market Share by Region (2019-2024)
Table 19. Global Preclinical DMPK Studies Revenue by Country/Region (2019-2024) & ($ millions)
Table 20. Global Preclinical DMPK Studies Revenue Market Share by Country/Region (2019-2024)
Table 21. Americas Preclinical DMPK Studies Market Size by Country (2019-2024) & ($ millions)
Table 22. Americas Preclinical DMPK Studies Market Size Market Share by Country (2019-2024)
Table 23. Americas Preclinical DMPK Studies Market Size by Type (2019-2024) & ($ millions)
Table 24. Americas Preclinical DMPK Studies Market Size Market Share by Type (2019-2024)
Table 25. Americas Preclinical DMPK Studies Market Size by Application (2019-2024) & ($ millions)
Table 26. Americas Preclinical DMPK Studies Market Size Market Share by Application (2019-2024)
Table 27. APAC Preclinical DMPK Studies Market Size by Region (2019-2024) & ($ millions)
Table 28. APAC Preclinical DMPK Studies Market Size Market Share by Region (2019-2024)
Table 29. APAC Preclinical DMPK Studies Market Size by Type (2019-2024) & ($ millions)
Table 30. APAC Preclinical DMPK Studies Market Size by Application (2019-2024) & ($ millions)
Table 31. Europe Preclinical DMPK Studies Market Size by Country (2019-2024) & ($ millions)
Table 32. Europe Preclinical DMPK Studies Market Size Market Share by Country (2019-2024)
Table 33. Europe Preclinical DMPK Studies Market Size by Type (2019-2024) & ($ millions)
Table 34. Europe Preclinical DMPK Studies Market Size by Application (2019-2024) & ($ millions)
Table 35. Middle East & Africa Preclinical DMPK Studies Market Size by Region (2019-2024) & ($ millions)
Table 36. Middle East & Africa Preclinical DMPK Studies Market Size by Type (2019-2024) & ($ millions)
Table 37. Middle East & Africa Preclinical DMPK Studies Market Size by Application (2019-2024) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Preclinical DMPK Studies
Table 39. Key Market Challenges & Risks of Preclinical DMPK Studies
Table 40. Key Industry Trends of Preclinical DMPK Studies
Table 41. Global Preclinical DMPK Studies Market Size Forecast by Region (2025-2030) & ($ millions)
Table 42. Global Preclinical DMPK Studies Market Size Market Share Forecast by Region (2025-2030)
Table 43. Global Preclinical DMPK Studies Market Size Forecast by Type (2025-2030) & ($ millions)
Table 44. Global Preclinical DMPK Studies Market Size Forecast by Application (2025-2030) & ($ millions)
Table 45. Charles River Details, Company Type, Preclinical DMPK Studies Area Served and Its Competitors
Table 46. Charles River Preclinical DMPK Studies Product Offered
Table 47. Charles River Preclinical DMPK Studies Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 48. Charles River Main Business
Table 49. Charles River Latest Developments
Table 50. Labcorp Details, Company Type, Preclinical DMPK Studies Area Served and Its Competitors
Table 51. Labcorp Preclinical DMPK Studies Product Offered
Table 52. Labcorp Preclinical DMPK Studies Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 53. Labcorp Main Business
Table 54. Labcorp Latest Developments
Table 55. Eurofins Scientific Details, Company Type, Preclinical DMPK Studies Area Served and Its Competitors
Table 56. Eurofins Scientific Preclinical DMPK Studies Product Offered
Table 57. Eurofins Scientific Preclinical DMPK Studies Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 58. Eurofins Scientific Main Business
Table 59. Eurofins Scientific Latest Developments
Table 60. PPD Details, Company Type, Preclinical DMPK Studies Area Served and Its Competitors
Table 61. PPD Preclinical DMPK Studies Product Offered
Table 62. PPD Preclinical DMPK Studies Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 63. PPD Main Business
Table 64. PPD Latest Developments
Table 65. Inotiv Details, Company Type, Preclinical DMPK Studies Area Served and Its Competitors
Table 66. Inotiv Preclinical DMPK Studies Product Offered
Table 67. Inotiv Preclinical DMPK Studies Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 68. Inotiv Main Business
Table 69. Inotiv Latest Developments
Table 70. ChemPartner Details, Company Type, Preclinical DMPK Studies Area Served and Its Competitors
Table 71. ChemPartner Preclinical DMPK Studies Product Offered
Table 72. ChemPartner Preclinical DMPK Studies Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 73. ChemPartner Main Business
Table 74. ChemPartner Latest Developments
Table 75. Evotec Details, Company Type, Preclinical DMPK Studies Area Served and Its Competitors
Table 76. Evotec Preclinical DMPK Studies Product Offered
Table 77. Evotec Preclinical DMPK Studies Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 78. Evotec Main Business
Table 79. Evotec Latest Developments
Table 80. Medicilon Details, Company Type, Preclinical DMPK Studies Area Served and Its Competitors
Table 81. Medicilon Preclinical DMPK Studies Product Offered
Table 82. Medicilon Preclinical DMPK Studies Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 83. Medicilon Main Business
Table 84. Medicilon Latest Developments
Table 85. Crown Bioscience Details, Company Type, Preclinical DMPK Studies Area Served and Its Competitors
Table 86. Crown Bioscience Preclinical DMPK Studies Product Offered
Table 87. Crown Bioscience Preclinical DMPK Studies Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 88. Crown Bioscience Main Business
Table 89. Crown Bioscience Latest Developments
Table 90. Jubilant Biosys Details, Company Type, Preclinical DMPK Studies Area Served and Its Competitors
Table 91. Jubilant Biosys Preclinical DMPK Studies Product Offered
Table 92. Jubilant Biosys Preclinical DMPK Studies Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 93. Jubilant Biosys Main Business
Table 94. Jubilant Biosys Latest Developments
Table 95. Creative Biolabs Details, Company Type, Preclinical DMPK Studies Area Served and Its Competitors
Table 96. Creative Biolabs Preclinical DMPK Studies Product Offered
Table 97. Creative Biolabs Preclinical DMPK Studies Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 98. Creative Biolabs Main Business
Table 99. Creative Biolabs Latest Developments
Table 100. Allucent Details, Company Type, Preclinical DMPK Studies Area Served and Its Competitors
Table 101. Allucent Preclinical DMPK Studies Product Offered
Table 102. Allucent Preclinical DMPK Studies Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 103. Allucent Main Business
Table 104. Allucent Latest Developments
Table 105. Sai Life Sciences Details, Company Type, Preclinical DMPK Studies Area Served and Its Competitors
Table 106. Sai Life Sciences Preclinical DMPK Studies Product Offered
Table 107. Sai Life Sciences Preclinical DMPK Studies Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 108. Sai Life Sciences Main Business
Table 109. Sai Life Sciences Latest Developments
Table 110. Sygnature Discovery Details, Company Type, Preclinical DMPK Studies Area Served and Its Competitors
Table 111. Sygnature Discovery Preclinical DMPK Studies Product Offered
Table 112. Sygnature Discovery Preclinical DMPK Studies Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 113. Sygnature Discovery Main Business
Table 114. Sygnature Discovery Latest Developments
Table 115. Q2 Solutions Details, Company Type, Preclinical DMPK Studies Area Served and Its Competitors
Table 116. Q2 Solutions Preclinical DMPK Studies Product Offered
Table 117. Q2 Solutions Preclinical DMPK Studies Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 118. Q2 Solutions Main Business
Table 119. Q2 Solutions Latest Developments
Table 120. Invitrocue Details, Company Type, Preclinical DMPK Studies Area Served and Its Competitors
Table 121. Invitrocue Preclinical DMPK Studies Product Offered
Table 122. Invitrocue Preclinical DMPK Studies Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 123. Invitrocue Main Business
Table 124. Invitrocue Latest Developments
Table 125. Frontage Details, Company Type, Preclinical DMPK Studies Area Served and Its Competitors
Table 126. Frontage Preclinical DMPK Studies Product Offered
Table 127. Frontage Preclinical DMPK Studies Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 128. Frontage Main Business
Table 129. Frontage Latest Developments
Table 130. BioDuro-Sundia Details, Company Type, Preclinical DMPK Studies Area Served and Its Competitors
Table 131. BioDuro-Sundia Preclinical DMPK Studies Product Offered
Table 132. BioDuro-Sundia Preclinical DMPK Studies Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 133. BioDuro-Sundia Main Business
Table 134. BioDuro-Sundia Latest Developments
Table 135. Wuxi AppTec Details, Company Type, Preclinical DMPK Studies Area Served and Its Competitors
Table 136. Wuxi AppTec Preclinical DMPK Studies Product Offered
Table 137. Wuxi AppTec Preclinical DMPK Studies Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 138. Wuxi AppTec Main Business
Table 139. Wuxi AppTec Latest Developments
Table 140. Pharmaron Details, Company Type, Preclinical DMPK Studies Area Served and Its Competitors
Table 141. Pharmaron Preclinical DMPK Studies Product Offered
Table 142. Pharmaron Preclinical DMPK Studies Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 143. Pharmaron Main Business
Table 144. Pharmaron Latest Developments
Table 145. JOINN Laboratories Details, Company Type, Preclinical DMPK Studies Area Served and Its Competitors
Table 146. JOINN Laboratories Preclinical DMPK Studies Product Offered
Table 147. JOINN Laboratories Preclinical DMPK Studies Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 148. JOINN Laboratories Main Business
Table 149. JOINN Laboratories Latest Developments
Table 150. Tigermed Details, Company Type, Preclinical DMPK Studies Area Served and Its Competitors
Table 151. Tigermed Preclinical DMPK Studies Product Offered
Table 152. Tigermed Preclinical DMPK Studies Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 153. Tigermed Main Business
Table 154. Tigermed Latest Developments



LIST OF FIGURES

Figure 1. Preclinical DMPK Studies Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Preclinical DMPK Studies Market Size Growth Rate 2019-2030 ($ millions)
Figure 6. Preclinical DMPK Studies Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Preclinical DMPK Studies Sales Market Share by Country/Region (2023)
Figure 8. Preclinical DMPK Studies Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Preclinical DMPK Studies Market Size Market Share by Type in 2023
Figure 10. Preclinical DMPK Studies in Pharmaceutical Companies
Figure 11. Global Preclinical DMPK Studies Market: Pharmaceutical Companies (2019-2024) & ($ millions)
Figure 12. Preclinical DMPK Studies in Medical Device Companies
Figure 13. Global Preclinical DMPK Studies Market: Medical Device Companies (2019-2024) & ($ millions)
Figure 14. Preclinical DMPK Studies in Others
Figure 15. Global Preclinical DMPK Studies Market: Others (2019-2024) & ($ millions)
Figure 16. Global Preclinical DMPK Studies Market Size Market Share by Application in 2023
Figure 17. Global Preclinical DMPK Studies Revenue Market Share by Player in 2023
Figure 18. Global Preclinical DMPK Studies Market Size Market Share by Region (2019-2024)
Figure 19. Americas Preclinical DMPK Studies Market Size 2019-2024 ($ millions)
Figure 20. APAC Preclinical DMPK Studies Market Size 2019-2024 ($ millions)
Figure 21. Europe Preclinical DMPK Studies Market Size 2019-2024 ($ millions)
Figure 22. Middle East & Africa Preclinical DMPK Studies Market Size 2019-2024 ($ millions)
Figure 23. Americas Preclinical DMPK Studies Value Market Share by Country in 2023
Figure 24. United States Preclinical DMPK Studies Market Size Growth 2019-2024 ($ millions)
Figure 25. Canada Preclinical DMPK Studies Market Size Growth 2019-2024 ($ millions)
Figure 26. Mexico Preclinical DMPK Studies Market Size Growth 2019-2024 ($ millions)
Figure 27. Brazil Preclinical DMPK Studies Market Size Growth 2019-2024 ($ millions)
Figure 28. APAC Preclinical DMPK Studies Market Size Market Share by Region in 2023
Figure 29. APAC Preclinical DMPK Studies Market Size Market Share by Type (2019-2024)
Figure 30. APAC Preclinical DMPK Studies Market Size Market Share by Application (2019-2024)
Figure 31. China Preclinical DMPK Studies Market Size Growth 2019-2024 ($ millions)
Figure 32. Japan Preclinical DMPK Studies Market Size Growth 2019-2024 ($ millions)
Figure 33. South Korea Preclinical DMPK Studies Market Size Growth 2019-2024 ($ millions)
Figure 34. Southeast Asia Preclinical DMPK Studies Market Size Growth 2019-2024 ($ millions)
Figure 35. India Preclinical DMPK Studies Market Size Growth 2019-2024 ($ millions)
Figure 36. Australia Preclinical DMPK Studies Market Size Growth 2019-2024 ($ millions)
Figure 37. Europe Preclinical DMPK Studies Market Size Market Share by Country in 2023
Figure 38. Europe Preclinical DMPK Studies Market Size Market Share by Type (2019-2024)
Figure 39. Europe Preclinical DMPK Studies Market Size Market Share by Application (2019-2024)
Figure 40. Germany Preclinical DMPK Studies Market Size Growth 2019-2024 ($ millions)
Figure 41. France Preclinical DMPK Studies Market Size Growth 2019-2024 ($ millions)
Figure 42. UK Preclinical DMPK Studies Market Size Growth 2019-2024 ($ millions)
Figure 43. Italy Preclinical DMPK Studies Market Size Growth 2019-2024 ($ millions)
Figure 44. Russia Preclinical DMPK Studies Market Size Growth 2019-2024 ($ millions)
Figure 45. Middle East & Africa Preclinical DMPK Studies Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Preclinical DMPK Studies Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Preclinical DMPK Studies Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Preclinical DMPK Studies Market Size Growth 2019-2024 ($ millions)
Figure 49. South Africa Preclinical DMPK Studies Market Size Growth 2019-2024 ($ millions)
Figure 50. Israel Preclinical DMPK Studies Market Size Growth 2019-2024 ($ millions)
Figure 51. Turkey Preclinical DMPK Studies Market Size Growth 2019-2024 ($ millions)
Figure 52. GCC Countries Preclinical DMPK Studies Market Size Growth 2019-2024 ($ millions)
Figure 53. Americas Preclinical DMPK Studies Market Size 2025-2030 ($ millions)
Figure 54. APAC Preclinical DMPK Studies Market Size 2025-2030 ($ millions)
Figure 55. Europe Preclinical DMPK Studies Market Size 2025-2030 ($ millions)
Figure 56. Middle East & Africa Preclinical DMPK Studies Market Size 2025-2030 ($ millions)
Figure 57. United States Preclinical DMPK Studies Market Size 2025-2030 ($ millions)
Figure 58. Canada Preclinical DMPK Studies Market Size 2025-2030 ($ millions)
Figure 59. Mexico Preclinical DMPK Studies Market Size 2025-2030 ($ millions)
Figure 60. Brazil Preclinical DMPK Studies Market Size 2025-2030 ($ millions)
Figure 61. China Preclinical DMPK Studies Market Size 2025-2030 ($ millions)
Figure 62. Japan Preclinical DMPK Studies Market Size 2025-2030 ($ millions)
Figure 63. Korea Preclinical DMPK Studies Market Size 2025-2030 ($ millions)
Figure 64. Southeast Asia Preclinical DMPK Studies Market Size 2025-2030 ($ millions)
Figure 65. India Preclinical DMPK Studies Market Size 2025-2030 ($ millions)
Figure 66. Australia Preclinical DMPK Studies Market Size 2025-2030 ($ millions)
Figure 67. Germany Preclinical DMPK Studies Market Size 2025-2030 ($ millions)
Figure 68. France Preclinical DMPK Studies Market Size 2025-2030 ($ millions)
Figure 69. UK Preclinical DMPK Studies Market Size 2025-2030 ($ millions)
Figure 70. Italy Preclinical DMPK Studies Market Size 2025-2030 ($ millions)
Figure 71. Russia Preclinical DMPK Studies Market Size 2025-2030 ($ millions)
Figure 72. Egypt Preclinical DMPK Studies Market Size 2025-2030 ($ millions)
Figure 73. South Africa Preclinical DMPK Studies Market Size 2025-2030 ($ millions)
Figure 74. Israel Preclinical DMPK Studies Market Size 2025-2030 ($ millions)
Figure 75. Turkey Preclinical DMPK Studies Market Size 2025-2030 ($ millions)
Figure 76. GCC Countries Preclinical DMPK Studies Market Size 2025-2030 ($ millions)
Figure 77. Global Preclinical DMPK Studies Market Size Market Share Forecast by Type (2025-2030)
Figure 78. Global Preclinical DMPK Studies Market Size Market Share Forecast by Application (2025-2030)


More Publications